147 related articles for article (PubMed ID: 33811)
1. Haemodynamic effects and pharmacokinetics of a new selective beta1-adrenoceptor agonist, prenalterol, and its interaction with metoprolol in man.
Rönn O; Graffner C; Johnsson G; Jordö L; Lundborg P; Wikstrand J
Eur J Clin Pharmacol; 1979 Feb; 15(1):9-13. PubMed ID: 33811
[TBL] [Abstract][Full Text] [Related]
2. Interaction in healthy volunteers between prenalterol, a selective beta 1-adrenoceptor agonist, and metoprolol or propranolol.
Rönn O; Johnsson G; Lundborg P
J Cardiovasc Pharmacol; 1981; 3(3):477-84. PubMed ID: 6168829
[TBL] [Abstract][Full Text] [Related]
3. Metabolic and haemodynamic effects and pharmacokinetics of a new selective beta 1-adrenoceptor agonist, prenalterol, in man.
Rönn O; Fellenius E; Graffner C; Johnsson G; Lundborg P; Svensson L
Eur J Clin Pharmacol; 1980 Feb; 17(2):81-6. PubMed ID: 6102914
[TBL] [Abstract][Full Text] [Related]
4. Immediate haemodynamic effects of prenalterol, a new adrenergic beta-1-receptor agonist, in healthy volunteers.
Svendsen TL; Hartling OJ; Trap-Jensen J
Eur J Clin Pharmacol; 1980 Oct; 18(3):219-23. PubMed ID: 6108219
[TBL] [Abstract][Full Text] [Related]
5. Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity?
Wirtzfeld A; Klein G; Bibra HV; Sauer E
Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):20-7. PubMed ID: 2859252
[TBL] [Abstract][Full Text] [Related]
6. Central and peripheral haemodynamic effects of prenalterol in patients with coronary heart disease.
Svendsen TL; Carlsen JE; Hartling OJ; Trap-Jensen J
Clin Physiol; 1981 Oct; 1(5):461-9. PubMed ID: 7199993
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of prenalterol (H133/22) in normal man.
Scott DH; Arthur GR; Boyes RN; Scott DB
Br J Clin Pharmacol; 1979 Apr; 7(4):365-70. PubMed ID: 36118
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic studies in man of the selective beta 1-adrenoceptor agonist, prenalterol.
Graffner C; Hoffmann KJ; Johnsson G; Lundborg P; Rönn O
Eur J Clin Pharmacol; 1981; 20(2):91-7. PubMed ID: 6114866
[TBL] [Abstract][Full Text] [Related]
9. Immediate central and regional haemodynamic effects of a new beta 1-adrenergic stimulating drug, xamoterol (Corwin) in healthy volunteers.
Tangø M; Carlsen JE; Trap-Jensen J
Eur J Clin Pharmacol; 1985; 29(2):155-8. PubMed ID: 2866963
[TBL] [Abstract][Full Text] [Related]
10. Heart-rate variability effects of beta-adrenoceptor agonists (xamoterol, prenalterol, and salbutamol) assessed nonlinearly with scatterplots and sequence methods.
Silke B; Hanratty CG; Riddell JG
J Cardiovasc Pharmacol; 1999 Jun; 33(6):859-67. PubMed ID: 10367588
[TBL] [Abstract][Full Text] [Related]
11. Ventilatory and haemodynamic effects of prenalterol and terbutaline in asthmatic patients.
Greefhorst AP; van Herwaarden CL
Eur J Clin Pharmacol; 1983; 24(2):173-8. PubMed ID: 6132819
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic effects of prenalterol in healthy subjects.
Johnsson G
Acta Med Scand Suppl; 1982; 659():109-22. PubMed ID: 6127882
[TBL] [Abstract][Full Text] [Related]
13. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
McCaffrey PM; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
[TBL] [Abstract][Full Text] [Related]
14. Ventilatory and haemodynamic effects of terbutaline infusion during beta 1-selective blockade with metoprolol and acebutolol in asthmatic patients.
Greefhorst AP; van Herwaarden CL
Eur J Clin Pharmacol; 1982; 23(3):203-8. PubMed ID: 6756931
[TBL] [Abstract][Full Text] [Related]
15. Haemodynamic effects of prenalterol in patients with coronary heart disease.
Hutton I; Murray RG; Boyes RN; Rae AP; Hillis WS
Br Heart J; 1980 Feb; 43(2):134-7. PubMed ID: 6102468
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic and tolerance studies in man of a new, orally active, selective beta1-adrenoceptor agonist H 80/62.
Johnsson G; Jordö L; Lundborg P; Rönn O; Welin-Fogelberg I; Wikstrand J
Eur J Clin Pharmacol; 1978 May; 13(3):163-70. PubMed ID: 27371
[No Abstract] [Full Text] [Related]
17. Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.
Rasmussen S; Høilund-Carlsen PF; Hesse B; Hartling OJ; Fabricius J; Dige-Petersen H; Giese J
Eur J Clin Pharmacol; 1984; 27(5):539-43. PubMed ID: 6151507
[TBL] [Abstract][Full Text] [Related]
18. Beta adrenergic influence on esophageal and colonic motility in man.
Lyrenäs E
Scand J Gastroenterol Suppl; 1985; 116():1-48. PubMed ID: 2864739
[TBL] [Abstract][Full Text] [Related]
19. Haemodynamic and cardiac metabolic effects of the new beta 1 agonist prenalterol in patients with cardiac failure.
Kupper W; Schütt M; Hamm CW; Kuck KH; Hanrath P; Bleifeld W
Eur Heart J; 1983 Aug; 4(8):573-83. PubMed ID: 6139281
[TBL] [Abstract][Full Text] [Related]
20. Haemodynamic effects, plasma concentrations and tolerance of orally administered prenalterol in man.
Weiss A; Pfister B; Imhof P; Degen PH; Burckhardt D; Dubach UC
Eur J Clin Pharmacol; 1980 Nov; 18(5):383-90. PubMed ID: 6108221
[No Abstract] [Full Text] [Related]
[Next] [New Search]
